Provenge

(Newser) - A first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease received federal approval today, offering an important alternative to more taxing treatments like chemotherapy. Dendreon Corp.'s Provenge vaccine trains the immune system to fight tumors. It's called a "vaccine" even though it treats...

(Newser) - A cancer drug that's the first to harness the body's immune system to destroy tumors got a thumbs-up from  the FDA's advisory panel, the New York Times reports. If approved, Provenge, a prostate cancer treatment, would be the first of the "cancer vaccines"—experimental therapies that commandeer a...